title: Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous.
authors: John B
authors: JB
authors: Christoforidis
authors: Michelle M
authors: MM
authors: Williams
authors: Frank M
authors: FM
authors: Epitropoulos
authors: Michael V
authors: MV
authors: Knopp
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000378:metabolism; D000818:Animals; D001768:Blister / Q000378:metabolism* / Q000473:pathology; D003229:Conjunctival Diseases / Q000378:metabolism* / Q000473:pathology; D058449:Intravitreal Injections; D007457:Iodine Radioisotopes; D049268:Positron-Emission Tomography; D011817:Rabbits; D040262:Receptors, Vascular Endothelial Growth Factor / Q000008:administration & dosage* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000378:metabolism; D014057:Tomography, X-Ray Computed; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D007457:Iodine Radioisotopes; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor